Results 211 to 220 of about 63,834 (278)

How Pre‐Pregnancy Weight and Polycystic Ovary Syndrome Impact Pregnancy Outcomes: A Population‐Based Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Pre‐pregnancy overweight/obese status among women with polycystic ovary syndrome (PCOS) could increase the risk of at least one adverse pregnancy outcome (APO). This study aimed to determine how pre‐pregnancy weight and PCOS impact pregnancy outcomes. Methods For the current study, we used data collected in the Tehran Lipid
Elahe Sheklabadi   +6 more
wiley   +1 more source

Thyroid dysfunction in African trypanosomiasis [PDF]

open access: yes, 1993
Allolio, B.   +9 more
core  

Carbohydrate‐Based Drug Discovery: Synthetic Strategies and Clinical Applications

open access: yesIsrael Journal of Chemistry, Volume 66, Issue 3, May 2026.
The picture depicts the molecules discussed in the review. On the left side, the general scaffold of sugars is shown. Next to it are four carbohydrate‐based molecules, including remdesivir, islatravir, empagliflozin, and Globo‐H. Remdesivir and islatravir contain a substituted ribose ring attached to a modified nucleobase.
Stephan Scheeff   +2 more
wiley   +1 more source

Association of polycystic ovarian syndrome with inflammatory single nucleotide polymorphism for IL-1 & IL-6 genes: A case-control study. [PDF]

open access: yesIndian J Med Res
Benjamin JJ   +8 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

First‐trimester preexisting diabetes screening in Medicaid beneficiaries

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Patients with public insurance have higher rates of pregestational diabetes mellitus (DM) and are less likely to receive preconception care than those with private insurance. First trimester DM screening rates among high‐risk publicly insured pregnant individuals in the United States are unknown.
Zeinab Kassem   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy